08225.HK
China Health Group Inc.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 0.08
−1.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 43.7M | 27.8M | 26.5M | 21.4M | 13.1M |
| Cost of Revenue | 20.8M | 11.9M | 16.4M | 13.2M | 7.3M |
| Gross Profit | 23.0M | 16.0M | 10.1M | 8.2M | 5.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 20.8M | 30.4M | 24.9M | 65.5M | 14.0M |
| General & Admin Expense | 2.5M | — | 10.1M | 7.6M | 14.0M |
| Selling & Marketing Expense | 13.2M | — | 14.8M | 57.9M | — |
| Other Expenses | (7.6M) | — | 29.0K | — | 7.8M |
| Total Operating Expenses | 13.2M | 30.4M | 24.9M | 65.5M | 21.8M |
| Cost and Expenses | 34.0M | 42.3M | 41.3M | 78.8M | 29.1M |
| Operating Income (EBIT) | 9.8M | (14.5M) | (14.8M) | (57.3M) | (16.1M) |
| Non-Operating | |||||
| Interest Income | — | 68.2K | 63.0K | 116.0K | 202.0K |
| Interest Expense | 2.0K | — | — | — | 17.0K |
| Net Interest Income | 33.0K | 68.2K | 63.0K | 116.0K | 185.0K |
| Other Non-Op Income/Expense | (31.0M) | (120.8K) | 372.0K | (884.0K) | 231.0K |
| Non-Operating Income (excl Interest) | 7.6M | — | — | 884.0K | (46.0K) |
| EBT (Pre-Tax Income) | (21.2M) | (14.6M) | (14.5M) | (58.2M) | (15.8M) |
| Income Tax Expense | 1.7M | — | 46.0K | — | 17.0K |
| Bottom Line | |||||
| Net Income | (9.6M) | (14.6M) | (14.5M) | (58.0M) | (15.8M) |
| Earnings from Cont. Ops | (9.6M) | (14.6M) | (14.5M) | (58.2M) | (15.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (9.6M) | (14.6M) | (14.5M) | (58.0M) | (15.8M) |
| Per Share | |||||
| Basic EPS | (HK$0.02) | (HK$0.01) | (HK$0.01) | (HK$0.06) | (HK$0.02) |
| Diluted EPS | (HK$0.02) | (HK$0.01) | (HK$0.01) | (HK$0.06) | (HK$0.02) |
| Revenue Per Share | HK$0.04 | HK$0.03 | HK$0.03 | HK$0.02 | HK$0.01 |
| Shares | |||||
| Basic Shares Outstanding | 995.4M | 995.4M | 994.5M | 995.4M | 995.3M |
| Diluted Shares Outstanding | 995.4M | 995.4M | 995.4M | 995.4M | 995.4M |
| Profitability Metrics | |||||
| EBITDA | 2.5M | (14.0M) | (14.2M) | (58.0M) | (15.7M) |
| D&A | 303.0K | 406.2K | 606.0K | 234.0K | 151.0K |
| EBIT | 2.2M | (14.5M) | (14.8M) | (58.2M) | (15.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026